Breaking a feedback loop: A reassessment of an investigator initiated <scp>OS‐AID</scp> study

Diabetes, Obesity and MetabolismEarly View LETTER TO THE EDITOR Breaking a feedback loop: A reassessment of an investigator initiated OS-AID study Katarina Braune MD, Katarina Braune MD orcid.org/0000-0001-6590-245X Institute of Medical Informatics, Charité - Universitätsmedizin Berlin, Berlin, GermanySearch for more papers by this authorSufyan Hussain MD, Sufyan Hussain MD orcid.org/0000-0001-6611-8245 Department of Diabetes and Endocrinology, Guy's & St Thomas' NHS Foundation Trust, London, UK Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, UKSearch for more papers by this authorRayhan Lal MD, Rayhan Lal MD orcid.org/0000-0002-8055-944X Department of Medicine & Pediatrics, Divisions of Endocrinology, Stanford University, Stanford, California, USASearch for more papers by this authorScott Leibrand BS, Scott Leibrand BS orcid.org/0009-0002-4394-4119 OpenAPS, Seattle, Washington, USASearch for more papers by this authorDana M. Lewis BA, Corresponding Author Dana M. Lewis BA dana@OpenAPS.org orcid.org/0000-0001-9176-6308 OpenAPS, Seattle, Washington, USA Correspondence Dana M. Lewis, OpenAPS, Seattle, WA, USA. Email: dana@OpenAPS.orgSearch for more papers by this authorShane O'Donnell PhD, Shane O'Donnell PhD orcid.org/0000-0002-3778-705X York University, Toronto, Ontario, CanadaSearch for more papers by this author Katarina Braune MD, Katarina Braune MD orcid.org/0000-0001-6590-245X Institute of Medical Informatics, Charité - Universitätsmedizin Berlin, Berlin, GermanySearch for more papers by this authorSufyan Hussain MD, Sufyan Hussain MD orcid.org/0000-0001-6611-8245 Department of Diabetes and Endocrinology, Guy's & St Thomas' NHS Foundation Trust, London, UK Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, UKSearch for more papers by this authorRayhan Lal MD, Rayhan Lal MD orcid.org/0000-0002-8055-944X Department of Medicine & Pediatrics, Divisions of Endocrinology, Stanford University, Stanford, California, USASearch for more papers by this authorScott Leibrand BS, Scott Leibrand BS orcid.org/0009-0002-4394-4119 OpenAPS, Seattle, Washington, USASearch for more papers by this authorDana M. Lewis BA, Corresponding Author Dana M. Lewis BA dana@OpenAPS.org orcid.org/0000-0001-9176-6308 OpenAPS, Seattle, Washington, USA Correspondence Dana M. Lewis, OpenAPS, Seattle, WA, USA. Email: dana@OpenAPS.orgSearch for more papers by this authorShane O'Donnell PhD, Shane O'Donnell PhD orcid.org/0000-0002-3778-705X York University, Toronto, Ontario, CanadaSearch for more papers by this author First published: 05 October 2023 https://doi.org/10.1111/dom.15301Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Open Research PEER REVIEW The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.15301. DATA AVAILABILITY STATEMENT Data sharing not applicable to this article as no datasets were generated or analysed in this letter to the editor. REFERENCES 1Künzler J, Züger T, Stettler C, Laimer MW, Melmer A. Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: an exploratory study. Diabetes Obes Metab. 2023; 13: 2780-2783. doi:10.1111/dom.15161 2Jeyaventhan R, Gallen G, Choudhary P, Hussain S. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G. Diabetes Obes Metab. 2021; 23(8): 1989-1994. doi:10.1111/dom.14439 3Toffanin C, Kozak M, Sumnik Z, Cobelli C, Petruzelkova L. In silico trials of an open-source android-based artificial pancreas: a new paradigm to test safety and efficacy of do-it-yourself systems. Diabetes Technol Ther. 2020; 22(2): 112-120. doi:10.1089/dia.2019.0375 4Reviewer 2. Comment in peer review. Diabetes Obes Metab. 2023. doi:10.1111/DOM.15161/V1/REVIEW2 5Reviewer 3. Comment in peer review. Diabetes Obes Metab. 2023. doi:10.1111/DOM.15161/V1/REVIEW3 6Crocket H. Peer mentoring in the do-it-yourself artificial pancreas system community. J Diabetes Sci Technol. 2020; 14(6): 1022-1027. doi:10.1177/1932296819883876 7Braune K, Lal RA, Petruželková L, et al. Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol. 2022; 10(1): 58-74. doi:10.1016/S2213-8587(21)00267-9 8Burnside MJ, Lewis DM, Crocket HR, et al. Open-source automated insulin delivery in type 1 diabetes. N Engl J Med. 2022; 387(10): 869-881. doi:10.1056/NEJMoa2203913 9Burnside MJ, Lewis DM, Crocket HR, et al. Extended use of an open-source automated insulin delivery system in children and adults with type 1 Diabetes: the 24-week continuation phase following the CREATE randomized controlled trial. Diabetes Technol Ther. 2023; 25(4): 250-259. doi:10.1089/dia.2022.0484 10Petruzelkova L, Neuman V, Plachy L, et al. First use of open-source automated insulin delivery AndroidAPS in full closed-loop scenario: Pancreas4ALL randomized pilot study. Diabetes Technol Ther. 2023; 25(5): 315-323. doi:10.1089/dia.2022.0562 11Nanayakkara N, Sharifi A, Burren D, Elghattis Y, Jayarathna DK, Cohen N. Hybrid closed loop using a do-it-yourself artificial pancreas system in adults with type 1 diabetes. J Diabetes Sci Technol. 2023;193229682311538. doi:10.1177/19322968231153882 12 NICE. NICE: Hybrid Closed Loop Systems for Managing Blood Glucose Levels in Type 1 Diabetes. https://www.nice.org.uk/guidance/indevelopment/gid-ta10845 13Sumnik Z, Szypowska A, Iotova V, et al. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: the SWEET perspective. Pediatr Diabetes. 2019; 20(4): 434-443. doi:10.1111/pedi.12833 14ElSayed NA, Aleppo G, Aroda VR, et al. 7. Diabetes technology: standards of care in diabetes—2023. Diabetes Care. 2023; 46(Supplement_1): S111-S127. doi:10.2337/dc23-S007 Citing Literature Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation